Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 4 studies | 24% ± 4% | |
| endothelial cell | 3 studies | 22% ± 3% | |
| epithelial cell | 3 studies | 21% ± 1% | |
| hepatocyte | 3 studies | 52% ± 28% | |
| GABAergic neuron | 3 studies | 33% ± 5% | |
| glutamatergic neuron | 3 studies | 33% ± 7% | |
| adipocyte | 3 studies | 20% ± 3% | |
| oligodendrocyte | 3 studies | 16% ± 0% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 26% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 4665.16 | 245 / 245 | 100% | 12.78 | 501 / 502 |
| esophagus | 100% | 2175.34 | 1445 / 1445 | 99% | 10.90 | 182 / 183 |
| pancreas | 100% | 3238.09 | 328 / 328 | 99% | 9.15 | 177 / 178 |
| breast | 100% | 3123.99 | 459 / 459 | 99% | 10.19 | 1110 / 1118 |
| bladder | 100% | 2348.71 | 21 / 21 | 99% | 8.39 | 499 / 504 |
| liver | 100% | 7737.36 | 226 / 226 | 99% | 12.70 | 401 / 406 |
| intestine | 100% | 2600.72 | 966 / 966 | 99% | 8.66 | 520 / 527 |
| lung | 100% | 2551.36 | 577 / 578 | 99% | 8.70 | 1139 / 1155 |
| thymus | 100% | 4453.72 | 653 / 653 | 98% | 9.77 | 595 / 605 |
| skin | 100% | 2462.86 | 1809 / 1809 | 98% | 8.62 | 464 / 472 |
| stomach | 100% | 2417.93 | 359 / 359 | 98% | 9.49 | 281 / 286 |
| uterus | 100% | 4352.34 | 170 / 170 | 98% | 8.48 | 450 / 459 |
| ovary | 100% | 5544.85 | 180 / 180 | 98% | 9.92 | 420 / 430 |
| kidney | 100% | 2513.98 | 89 / 89 | 97% | 26.21 | 878 / 901 |
| adrenal gland | 100% | 3698.12 | 258 / 258 | 96% | 7.71 | 221 / 230 |
| brain | 96% | 1568.29 | 2547 / 2642 | 94% | 6.06 | 664 / 705 |
| adipose | 100% | 2668.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3692.88 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 7.74 | 45 / 45 |
| blood vessel | 100% | 2125.53 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 1501.99 | 795 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 3549.54 | 919 / 929 | 0% | 0 | 0 / 0 |
| heart | 98% | 2741.76 | 840 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 7.18 | 28 / 29 |
| eye | 0% | 0 | 0 / 0 | 96% | 7.47 | 77 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005975 | Biological process | carbohydrate metabolic process |
| GO_0006091 | Biological process | generation of precursor metabolites and energy |
| GO_0036211 | Biological process | protein modification process |
| GO_0005977 | Biological process | glycogen metabolic process |
| GO_0005964 | Cellular component | phosphorylase kinase complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005516 | Molecular function | calmodulin binding |
| GO_0004689 | Molecular function | phosphorylase kinase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PHKA2 |
| Protein name | Phosphorylase kinase alpha-subunit (EC 2.7.1.38) Phosphorylase b kinase regulatory subunit alpha, liver isoform (Phosphorylase kinase alpha L subunit) |
| Synonyms | PHKLA PYK |
| Description | FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The alpha chain may bind calmodulin. |
| Accessions | O60912 P46019 ENST00000379942.5 |
